GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Asset Turnover

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Asset Turnover : 1.26 (As of Sep. 2017)


View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Proto Script Pharmaceutical's Revenue for the three months ended in Sep. 2017 was $0.25 Mil. Proto Script Pharmaceutical's Total Assets for the quarter that ended in Sep. 2017 was $0.20 Mil. Therefore, Proto Script Pharmaceutical's Asset Turnover for the quarter that ended in Sep. 2017 was 1.26.

Asset Turnover is linked to ROE % through Du Pont Formula. Proto Script Pharmaceutical's annualized ROE % for the quarter that ended in Sep. 2017 was 87.38%. It is also linked to ROA % through Du Pont Formula. Proto Script Pharmaceutical's annualized ROA % for the quarter that ended in Sep. 2017 was -566.58%.


Proto Script Pharmaceutical Asset Turnover Historical Data

The historical data trend for Proto Script Pharmaceutical's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Asset Turnover Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Asset Turnover
- - - - -

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.46 0.69 0.58 1.26

Competitive Comparison of Proto Script Pharmaceutical's Asset Turnover

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proto Script Pharmaceutical's Asset Turnover Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Asset Turnover falls into.



Proto Script Pharmaceutical Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Proto Script Pharmaceutical's Asset Turnover for the fiscal year that ended in May. 2016 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: May. 2016 )/( (Total Assets (A: May. 2015 )+Total Assets (A: May. 2016 ))/ count )
=0/( (0.001+0.012)/ 2 )
=0/0.0065
=0.00

Proto Script Pharmaceutical's Asset Turnover for the quarter that ended in Sep. 2017 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2017 )/( (Total Assets (Q: Jun. 2017 )+Total Assets (Q: Sep. 2017 ))/ count )
=0.252/( (0.166+0.235)/ 2 )
=0.252/0.2005
=1.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Proto Script Pharmaceutical  (OTCPK:PSCR) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Proto Script Pharmaceutical's annulized ROE % for the quarter that ended in Sep. 2017 is

ROE %**(Q: Sep. 2017 )
=Net Income/Total Stockholders Equity
=-1.136/-1.3
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.136 / 1.008)*(1.008 / 0.2005)*(0.2005/ -1.3)
=Net Margin %*Asset Turnover*Equity Multiplier
=-112.7 %*5.0274*-0.1542
=ROA %*Equity Multiplier
=-566.58 %*-0.1542
=87.38 %

Note: The Net Income data used here is four times the quarterly (Sep. 2017) net income data. The Revenue data used here is four times the quarterly (Sep. 2017) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Proto Script Pharmaceutical's annulized ROA % for the quarter that ended in Sep. 2017 is

ROA %(Q: Sep. 2017 )
=Net Income/Total Assets
=-1.136/0.2005
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-1.136 / 1.008)*(1.008 / 0.2005)
=Net Margin %*Asset Turnover
=-112.7 %*5.0274
=-566.58 %

Note: The Net Income data used here is four times the quarterly (Sep. 2017) net income data. The Revenue data used here is four times the quarterly (Sep. 2017) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Proto Script Pharmaceutical Asset Turnover Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines